57055--6/26/2008--KV_PHARMACEUTICAL_CO

related topics

{acquisition, growth, future}

{property, intellectual, protect}

{provision, law, control}

{tax, income, asset}

{customer, product, revenue}

{product, liability, claim}

{stock, price, share}

{financial, litigation, operation}

{product, market, service}

{cost, regulation, environmental}

{product, candidate, development}

{competitive, industry, competition}

{personnel, key, retain}

LITIGATION AND GOVERNMENT ENFORCEMENT ACTIONS. WHICH COULD HAVE A MATERIAL ADVERSE EFFECT ON OUR BUSINESS. WE ACQUIRE, OUR FUTURE OPERATING RESULTS MAY SUFFER. OUR ACQUISITION STRATEGY MAY NOT BE SUCCESSFUL. CERTAIN OF THEIR CONFIDENTIALITY AND PROTECTION. WE DEPEND ON OUR TRADEMARKS AND RELATED RIGHTS. OR SEEK TO CIRCUMVENT OURS. WE MAY BE UNABLE TO MANAGE OUR GROWTH. DEVELOPMENT AND MANAGEMENT OF OUR BUSINESS. DISTRIBUTION NETWORK AND THE CONCENTRATION OF OUR CUSTOMER BASE. REQUIRE MARKET WITHDRAWAL OF ONE OR MORE OF OUR UNAPPROVED PRODUCTS. COULD HARM OUR BUSINESS, MARKET SHARE AND PROFITABILITY. ADVERSELY AFFECT OUR BUSINESS. RISING INSURANCE COSTS COULD NEGATIVELY IMPACT PROFITABILITY. PRICING, AND OUR COSTS TO MANUFACTURE OR PURCHASE PRODUCTS. SECURITIES WILL RESULT IN DILUTION. AND MAY INCUR IMPAIRMENT CHARGES TO OUR INVESTMENT PORTFOLIO. WE MAY INCUR CHARGES FOR INTANGIBLE ASSET IMPAIRMENT. MARKETING, PRICING AND DEMAND FOR OUR PRODUCTS. PRODUCT DEVELOPMENT, MANUFACTURING AND DISTRIBUTION CAPABILITIES. OF OUR CLASS A OR CLASS B COMMON STOCK. MANAGEMENT SHAREHOLDERS CONTROL OUR COMPANY. OUR CHARTER PROVISIONS AND DELAWARE LAW MAY HAVE ANTI-TAKEOVER EFFECTS.

Full 10-K form ▸

57055--6/26/2008--KV_PHARMACEUTICAL_CO_/DE/